Ketamine-Assisted PsychoTherapy ViAbility in Treating Cancer-related Emotional Distress

This open-label trial (n=0; withdrawn) was designed to investigate the viability of ketamine-assisted psychotherapy in treating emotional distress related to cancer.

Conducted by Northwell Health, the study aimed to determine if three sessions of Ketamine Assisted Psychotherapy (KAP) during palliative radiation therapy are safe, feasible, and effective in reducing psychological distress.

Patients with moderate-severe cancer-related anxiety or depression undergoing palliative radiation therapy were eligible. Each KAP session, lasting approximately 3 hours, involved the administration of an individualized dose of Ketalar intramuscularly, followed by discussions with a trained psychotherapist. Integration sessions were scheduled the day after each KAP session and one month after the final session.

The primary outcome measure was the percentage of patients completing at least one KAP session, with secondary measures including depression, anxiety, and existential distress levels. The study, with the ClinicalTrials.gov ID NCT05344625, was anticipated to start in October 2023 and conclude by March 15, 2024. However, as of January 24, 2024, the study has been withdrawn by the research team, and no participants have been enrolled.

Topic Palliative Care
Compound Ketamine
Country United States of America
Visit trial
Status Withdrawn
Results Published No
Start date 31 October 2023
End date 15 March 2024
Phase Phase I
Design Open
Type Interventional
Generation First
Participants 0
Sex All
Age 21- 65
Therapy Yes

Trial Details

The present study will investigate if ketamine-assisted psychotherapy during palliative radiation therapy is safe, feasible, and effective at reducing psychological distress.

NCT Number NCT05344625

Sponsors & Collaborators

Northwell Health
This company doesn't have a full profile yet, it is linked to a clinical trial.

Data attribution

A large set of the trials in our database are sourced from ClinicalTrials.gov (CTG). We have modified these post to display the information in a more clear format or to correct spelling mistakes. Our database in actively updated and may show a different status (e.g. completed) if we have knowledge of this update (e.g. a published paper on the study) which isn't reflected yet on CTG. If a trial is not sourced from CTG, this is indicated on this page and you can follow the link to the alternative source of information.